Case Studies of Steriliser and Washer Qualification Failures and CAPA



Case Studies of Steriliser and Washer Qualification Failures and CAPA

Published on 18/11/2025

Case Studies of Steriliser and Washer Qualification Failures and CAPA

In the pharmaceutical industry, the qualification of sterilizers and washing equipment is an integral part of ensuring product quality and patient safety. Compliance with regulatory requirements from authorities such as the FDA, EMA, and MHRA is vital. This article presents a comprehensive guide containing case studies of steriliser and washer qualification failures and the corresponding Corrective and Preventive Actions (CAPA) implemented to remedy these issues. By examining these failures, we aim to provide valuable insights that can help pharmaceutical professionals avoid similar pitfalls.

Understanding Steriliser and Washer Qualification

The first step in addressing steriliser and washer qualification failures is to understand the process and requirements of validation, which are guided by Good Manufacturing Practices (cGMP). Equipment qualification is typically categorized into Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Each stage is critical in

ensuring that the equipment operates appropriately and produces consistent, sterile products.

1. **Installation Qualification (IQ)**: The IQ process verifies that the equipment has been installed according to manufacturer specifications and that it is suitable for its intended purpose. This includes checking electrical connections, measuring physical dimensions, and confirming that all components are present and functioning correctly.

2. **Operational Qualification (OQ)**: The OQ phase establishes that the steriliser or washer operates within specified limits across its defined operating range. Variables such as temperature, pressure, and cycle time are meticulously validated against predefined criteria.

3. **Performance Qualification (PQ)**: The PQ stage confirms that the equipment performs its intended function consistently, producing the desired sterility assurance level (SAL). This involves using biological indicators (BIs) and performing numerous sterilization cycles to demonstrate efficacy under worst-case conditions.

It is critical to document all phases rigorously, as thorough documentation serves as evidence for compliance with regulatory standards and for troubleshooting any failures or deviations in the qualification process.

Case Study 1: Failed Biological Indicators in Steam Sterilization

In a manufacturing facility, a steam sterilizer was qualified using biological indicators (BIs) to ensure effective sterilisation. During several validation cycles, however, the BIs failed to meet the expected sterility results, leading to a disconcerting steriliser qualification failure case.

**Root Cause Investigation**:

  • The initial investigation indicated inconsistent loading patterns in the sterilizer.
  • Further analysis revealed that the positioning of BIs within the sterilization load created scenarios where steam penetration was inadequate.
  • Temperature deviations during the sterilisation cycle were also identified, sparking concerns regarding the accuracy of the temperature sensors.

**Corrective Actions**:

  • Rerouting BI placement within the steriliser was implemented based on the findings to ensure optimal steam penetration.
  • Thermocouples were recalibrated to ensure accuracy, and routine monitoring was instituted to detect future deviations.
  • Additional operator training was provided to reinforce proper loading techniques and procedures.

**Preventive Actions**:

  • Creation of a standard operating procedure (SOP) for positioning BIs and verifying correct placement prior to sterilization.
  • Regular equipment performance reviews and periodic re-testing of BIs with rigorous documentation maintained for inspections by regulatory authorities.

Case Study 2: Temperature Deviations in a Depyrogenation Tunnel

A pharmaceutical manufacturing facility experienced significant temperature deviations during the validation of a depyrogenation tunnel. This failure raised serious concerns regarding the ability to effectively eliminate pyrogens from glass vials.

**Root Cause Investigation**:

  • Initial assessments revealed inconsistent temperature profiles; peak temperatures rarely reached the required 300°C for the mandated duration.
  • Further investigation pointed to malfunctions in the heating elements and inadequate thermal insulation in some sections of the tunnel.
  • Data logs showed that the control system did not adequately respond to the variations, indicating a calibration issue.

**Corrective Actions**:

  • Immediate inspection and replacement of faulty heating elements enhanced the heating efficiency.
  • Insulation materials were upgraded, and additional thermocouples were installed to monitor system accuracy.
  • A new validation cycle was executed with standardized conditions documented thoroughly.

**Preventive Actions**:

  • Introduction of a preventative maintenance schedule to ensure regular inspections and functionality tests of the depyrogenation equipment.
  • Implementation of a comprehensive temperature mapping study to validate and confirm heat distribution in the entire depyrogenation space.

Case Study 3: Non-compliance with Washer Validation Protocols

A major factor contributing to washer qualification failures is the lack of compliance with established validation protocols. In one case, a washer used for cleaning critical components in aseptic processing failed to meet required cleanliness standards during qualification testing.

**Root Cause Investigation**:

  • Review of the washer validation documentation indicated that critical cleaning parameters (e.g., wash temperature, detergent concentration, and cycle duration) were not rigorously adhered to during the qualification runs.
  • A deeper analysis uncovered that the personnel responsible for validation had a misunderstanding of the requirements outlined in the cleaning validation protocol.

**Corrective Actions**:

  • Immediate retraining of personnel on cleaning validation protocols and cGMP requirements.
  • Re-validation of the washer process was conducted following the established protocols to ensure compliance.
  • Retesting was performed on all impacted batches to ensure product safety and quality.

**Preventive Actions**:

  • Developing a robust training curriculum for all staff involved in equipment validation processes.
  • Conducting quarterly audits of cleaning and sterilization processes to ensure ongoing compliance with established protocols.

Lessons Learned: Best Practices for Future Qualification Success

The case studies presented above underline specific issues that can occur during steriliser and washer qualifications, along with the effective CAPA procedures adopted to address and prevent future failures. To enhance qualification success in the future, consider the following best practices:

  • Thorough Documentation: Documenting each phase of equipment qualification, along with any deviations and the rationale for decisions made, is essential for regulatory compliance.
  • Comprehensive Training: Ensure that all personnel involved in qualifications are adequately trained and familiar with all relevant procedures and regulations.
  • Regular Maintenance and Calibration: Establish a preventive maintenance schedule for continuous equipment oversight, including regular calibration checks of critical sensors and equipment.
  • Robust Change Control Procedures: Implement a strong change control process to assess the impact of modifications to equipment or processes on validated status.
  • Cross-Functional Communication: Encourage collaboration between validation, quality assurance, and production teams to strengthen operational consistency and establish clear expectations.

Conclusion

Understanding the complexities surrounding the qualification of sterilizers and washers in the pharmaceutical industry, including the potential for failures, is crucial for maintaining compliance with regulatory standards and ensuring product safety. The case studies outlined provide valuable insights into corrective and preventive actions that can be leveraged by pharmaceutical validation professionals. By incorporating these lessons learned and adopting best practices, organizations can enhance their validation efforts, ultimately contributing to the integrity of products delivered to the market.